TY  - JOUR
AU  - Hajji, Nabil
AU  - García-Domínguez, Daniel J
AU  - Hontecillas-Prieto, Lourdes
AU  - O'Neill, Kevin
AU  - de Álava, Enrique
AU  - Syed, Nelofer
PY  - 2018
DO  - 10.2217/epi-2017-0112
UR  - https://hdl.handle.net/10668/26722
T2  - Epigenomics
AB  - One of the major obstacles to the development of effective new cancer treatments and the main factor for the increasing number of clinical trial failures appears to be the paucity of accurate, reproducible and robust drug resistance testing methods....
LA  - en
KW  - cancer epigenetics
KW  - epigenetic regulations
KW  - epigenetic therapies
KW  - Antineoplastic Agents
KW  - DNA Methylation
KW  - Drug Resistance, Neoplasm
KW  - Epigenesis, Genetic
KW  - Histone Deacetylases
KW  - Humans
KW  - MicroRNAs
KW  - Neoplasms
TI  - The bitter side of epigenetics: variability and resistance to chemotherapy.
TY  - research article
VL  - 13
ER  -